Renaissance Capital logo

CABA News

US IPO Week Ahead: Another quiet week for the IPO market with 1 biotech

WIMI

Updated on Monday, April 20, 2020. One biotech IPO is scheduled for the week ahead, and pipeline activity indicates that a few more may be on the way. ORIC Pharmaceuticals (ORIC), a Phase 1 biotech developing small molecule therapies for...read more

US IPO Weekly Recap: IPO market serves up tricks and treats in diverse 8-IPO week

ONEW

In the busiest week since July, eight companies entered the public market while recreational boat retailer OneWater Marine (ONEW) postponed its $60 million deal. Two insurance plays and a biotech traded up more than 15%, while ...read more

Autoimmune biotech Cabaletta Bio prices IPO well below the range at $11

Cabaletta Bio logo

Cabaletta Bio, a Phase 1-ready biotech developing engineered T cells for autoimmune diseases, raised $75 million by offering 6.8 million shares at $11, below the range of $14 to $16. The company sold 1.0 million more shares than expected. At the offer price,...read more

US IPO Week Ahead: IPO market ramps up with 8 deals despite investor caution

PGNY

Up to eight companies are set to raise $831 million in the week ahead. Florida insurance brokerage BRP Group (BRP) is the largest by deal size, while employee benefits provider Progyny (PGNY) and Chinese...read more